LONDON, UK AND PLANO, TX, February 6, 2020. Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems for treating patients suffering from acute respiratory distress syndrome (ARDS). The latest patent application covers devices and […]
https://www.belluscura.com/wp-content/uploads/2020/02/0a1-11.jpg5621000Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2020-02-06 19:48:322020-10-07 15:34:00Belluscura announces filing of a patent application on an oxygen enrichment device and system for treating acute respiratory distress (ARDS), including ARDS caused by the recent Coronavirus
LONDON, UK AND PLANO, TX, August 2, 2019. Belluscura PLC announces the successful close of its latest fundraising round. Raising $2.7m, the private placing was priced at US$0.185 (15p) per share, giving Belluscura a post-money valuation of approximately US$9.0m. Beginning with an over-subscribed UK crowdfunding campaign on CrowdCube earlier this year, 12 existing shareholders and […]
LONDON, UK AND PLANO, TX April 23, 2019. Belluscura PLC is excited to announce that its crowdfunding campaign has exceeded the target raise of £500,000 ($647,000 USD). The campaign will remain open on Crowdcube (https://www.crowdcube.com) until May 3 to allow additional people the opportunity to invest in the company. This raise will enable Belluscura to […]
https://www.belluscura.com/wp-content/uploads/2019/04/images-1.jpg183275Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-04-23 12:43:362020-10-07 15:59:26BELLUSCURA’S CROWDFUNDING CAMPAIGN ON CROWDCUBE IS OVERFUNDED
A substantial new investment has brought our Crowdcube crowdfunding effort to 91% of our funding goal! We are thrilled and humbled to be supported by all the people who, like us, want to improve the lives of millions suffering from chronic lung diseases.
https://www.belluscura.com/wp-content/uploads/2019/04/136825_00_2x.jpg7901184Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-04-18 08:43:522020-10-07 16:00:04Belluscura reaches 91% of target on Crowdcube
The Global Group UK Investor Show is UK’s number 1 investor event, owned by the Wray family. This year’s show took place March 30, featuring 125+ exhibitors and attracting 2,500 attendees. Investors that visited the Belluscura booth had the opportunity to meet the company CEO Bob Rauker and CFO Tony Dyer and learn more about […]
https://www.belluscura.com/wp-content/uploads/2019/04/City_Hall_London_rm.jpg8001200Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-04-03 12:37:342020-10-07 16:03:06Belluscura well-received at the UK Investor Show
LONDON, UK AND PLANO, TX Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the recent filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems. The latest patent application covers systems for treating people suffering from acute respiratory distress syndrome (ARDS). Typical causes of […]
https://www.belluscura.com/wp-content/uploads/2019/04/0314_637231154360543565.jpg6661000Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-03-30 08:03:392020-10-07 16:10:04Belluscura announces filing of a patent application covering novel portable extracorporeal oxygenation and carbon dioxide removal systems for the treatment of acute respiratory distress syndrome (ARDS)
Visit Belluscura at Booth 65 at the UK Investor Show! See a live demonstration of the X-PLO2R portable oxygen concentrator, learn more about its unique technology and multiple advantages, and meet Belluscura’s CEO Bob Rauker and CFO Tony Dyer. Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or […]
https://www.belluscura.com/wp-content/uploads/2019/03/UK-Investors-Show-Clean.jpg536850Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-03-28 09:23:522020-10-07 16:17:04Belluscura to present at UK Investor Show this Saturday
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy
Belluscura announces filing of a patent application on an oxygen enrichment device and system for treating acute respiratory distress (ARDS), including ARDS caused by the recent Coronavirus
/in Belluscura News /by BelluscuraLONDON, UK AND PLANO, TX, February 6, 2020. Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems for treating patients suffering from acute respiratory distress syndrome (ARDS). The latest patent application covers devices and […]
Belluscura PLC raises $2.7 million in latest financing round
/in Belluscura News /by BelluscuraLONDON, UK AND PLANO, TX, August 2, 2019. Belluscura PLC announces the successful close of its latest fundraising round. Raising $2.7m, the private placing was priced at US$0.185 (15p) per share, giving Belluscura a post-money valuation of approximately US$9.0m. Beginning with an over-subscribed UK crowdfunding campaign on CrowdCube earlier this year, 12 existing shareholders and […]
BELLUSCURA’S CROWDFUNDING CAMPAIGN ON CROWDCUBE IS OVERFUNDED
/in Belluscura News /by BelluscuraLONDON, UK AND PLANO, TX April 23, 2019. Belluscura PLC is excited to announce that its crowdfunding campaign has exceeded the target raise of £500,000 ($647,000 USD). The campaign will remain open on Crowdcube (https://www.crowdcube.com) until May 3 to allow additional people the opportunity to invest in the company. This raise will enable Belluscura to […]
Belluscura reaches 91% of target on Crowdcube
/in Belluscura News /by BelluscuraA substantial new investment has brought our Crowdcube crowdfunding effort to 91% of our funding goal! We are thrilled and humbled to be supported by all the people who, like us, want to improve the lives of millions suffering from chronic lung diseases.
Belluscura well-received at the UK Investor Show
/in Belluscura News /by BelluscuraThe Global Group UK Investor Show is UK’s number 1 investor event, owned by the Wray family. This year’s show took place March 30, featuring 125+ exhibitors and attracting 2,500 attendees. Investors that visited the Belluscura booth had the opportunity to meet the company CEO Bob Rauker and CFO Tony Dyer and learn more about […]
HME News features X-PLOR
/in Belluscura News /by BelluscuraBelluscura announces filing of a patent application covering novel portable extracorporeal oxygenation and carbon dioxide removal systems for the treatment of acute respiratory distress syndrome (ARDS)
/in Belluscura News /by BelluscuraLONDON, UK AND PLANO, TX Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the recent filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems. The latest patent application covers systems for treating people suffering from acute respiratory distress syndrome (ARDS). Typical causes of […]
Belluscura to present at UK Investor Show this Saturday
/in Belluscura News /by BelluscuraVisit Belluscura at Booth 65 at the UK Investor Show! See a live demonstration of the X-PLO2R portable oxygen concentrator, learn more about its unique technology and multiple advantages, and meet Belluscura’s CEO Bob Rauker and CFO Tony Dyer. Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or […]